Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Research

The FDA Foundation Research Program works to accelerate and improve the availability of safe and effective medical products.
Research & Analysis
  • Read more about Research

Expanded Access Navigator

The Expanded Access Navigator, or EA Navigator, represents a unique partnership between the Reagan-Udall Foundation for the FDA, patient advocacy organizations, the pharmaceutical industry, and the federal government to provide clear, digestible information on single-patient EA.
Learn More
Patient, Provider & Consumer Services
  • Read more about Expanded Access Navigator

Reliability and Concordance of 15-m Sprint Performance on Sand and Firm Surfaces

  • Read more about Reliability and Concordance of 15-m Sprint Performance on Sand and Firm Surfaces

Bio-Manguinhos/Fiocruz COVID-19 (mRNA) Vaccine Booster

  • Read more about Bio-Manguinhos/Fiocruz COVID-19 (mRNA) Vaccine Booster

A Randomized, Double-blind, Multicentre, Placebo-controlled Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Participants With Respiratory Insufficiency Expected to be Caused by Infection With

  • Read more about A Randomized, Double-blind, Multicentre, Placebo-controlled Clinical Trial Evaluating the Safety and Efficacy of AP1189 Versus Placebo as an add-on to Standard of Care in Participants With Respiratory Insufficiency Expected to be Caused by Infection With

BALance: ARDS Deconvolution by Bronchoalveolar Lavage Multiomics and Radiomics

  • Read more about BALance: ARDS Deconvolution by Bronchoalveolar Lavage Multiomics and Radiomics

Nouscom AG

By jpalfreyman on Mon, 06/08/2026 - 12:59
  • Read more about Nouscom AG

Phase 4 Study of Sto M Tab. in Acute or Chronic Gastritis

  • Read more about Phase 4 Study of Sto M Tab. in Acute or Chronic Gastritis

Evaluating the Safety and Efficacy of PNMR as Treatment for Long COVID

  • Read more about Evaluating the Safety and Efficacy of PNMR as Treatment for Long COVID

Diaphragmatic Breathing Exercises With KOTS Currents in Patients With Long COVID

  • Read more about Diaphragmatic Breathing Exercises With KOTS Currents in Patients With Long COVID

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA